Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2Phase NA 1

Status

Completed 78Recruiting 35Unknown 34Terminated 21Active not recruiting 13Not yet recruiting 5Withdrawn 4Suspended 1

Sponsor Class

OTHER 108INDUSTRY 5OTHER_GOV 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Breast 1

Conditions

Pancreatic Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Injections 36Carboplatin 31Paclitaxel 24Docetaxel 24Capecitabine 24Gemcitabine 22Cisplatin 22pembrolizumab 21Oxaliplatin 21Bevacizumab 20Pemetrexed 18Fluorouracil 13Irinotecan 12Cyclophosphamide 11Nivolumab 8osimertinib 7Topotecan 7Leucovorin 7Dexamethasone 7toripalimab 6tislelizumab 6regorafenib 6lenvatinib 6fludarabine 6Trastuzumab 6Doxorubicin 6Cetuximab 6130-nm albumin-bound paclitaxel 6venetoclax 5Temozolomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Drug Therapy × Clear all
NCT07556848 2026-04-30

A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 3 Not yet recruiting
356 enrolled
Breast

Triple Negative Breast Neoplasms

NCT07498725 2026-03-27

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

LARKSPUR BIOSCIENCES, INC.

Phase 1/2 Not yet recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

Shanghai JMT-Bio Inc.

Phase 1/2 Not yet recruiting
596 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

IMGT Co., Ltd.

Phase NA Not yet recruiting
136 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Genfleet Therapeutics (Shanghai) Inc.

Phase 3 Not yet recruiting
320 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡